Cargando…
A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy. Patient prognosis cannot be accurately assessed in National Comprehensive Cancer Network (NCCN) risk stratification subgroups based on the current criteria. This study aimed to develop a novel prognostic score mode...
Autores principales: | Yu, Yang, Wang, Hao, Yang, Jing-Jing, Fang, Shu, Wen, Ya-Nan, Jiao, Yi-Fan, Qian, Kun, Le, Ning, Shan, Ruo-Qi, Gao, Wen-Jing, Hua, Bao-Lai, Li, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098320/ https://www.ncbi.nlm.nih.gov/pubmed/37064135 http://dx.doi.org/10.3389/fonc.2023.1144403 |
Ejemplares similares
-
Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023) -
Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
por: Pan, Jingjing, et al.
Publicado: (2022) -
Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients
por: Ye, Zhitao, et al.
Publicado: (2022) -
Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
por: Zhong, Fang-Min, et al.
Publicado: (2022) -
Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
por: Li, Mei-Yong, et al.
Publicado: (2021)